Skip to main content
Clinical Trials/ChiCTR1800018367
ChiCTR1800018367Not yet recruitingNot Applicable

右美托咪定对口腔鳞状细胞癌根治术患者围术期的影响

自费1 site in 1 country60 target enrollmentStarted: October 1, 2018Last updated:

Trial Snapshot

Phase
Not Applicable
Status
Not yet recruiting
Sponsor
Enrollment
60
Locations
1
Primary Endpoint
麻醉药的用量

Study Overview

Brief Summary

观察右美托咪定对口腔鳞状细胞癌根治术患者围术期的影响,是否能减少术中麻醉药及镇痛药的总剂量,并对患者术后寒战、躁动和谵妄给予评估,以及观察患者在 ICU 的耐管程度

Study Design

Study Type
干预性研究
Primary Purpose
随机平行对照
Masking
未说明

Eligibility Criteria

Ages
40 to 70 (—)
Sex
All

Inclusion Criteria

  • 选择口腔鳞状细胞癌行根治术和同期皮瓣转移缺损修复术患者 60 名;年龄 40-70 岁;ASAI-II 级;TNM 分期为 0-1 期

Exclusion Criteria

  • 排除窦性心动过缓、血压不稳定以及对右美托咪定过敏的患者

Arms & Interventions

右美托咪定组

使用右美托咪定

对照组

不使用右美托咪定

Outcomes

Primary Outcomes

麻醉药的用量

术后寒战

术后躁动

术后谵妄

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
自费

Study Sites (1)

Loading locations...

Similar Trials